Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Filing date	Form	Description	View
Mar 11, 2016	8-K	Report of unscheduled material events or corporate event	View HTML 0001558370-16-004036.pdf 0001558370-16-004036.rtf 0001558370-16-004036.xls
Mar 11, 2016	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001558370-16-004066.pdf 0001558370-16-004066.rtf 0001558370-16-004066.xls EX-101.INS - EX-101.INS
Mar 11, 2016	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0001558370-16-004067.pdf 0001558370-16-004067.rtf 0001558370-16-004067.xls
Mar 18, 2016	8-K	Report of unscheduled material events or corporate event	View HTML 0001558370-16-004244.pdf 0001558370-16-004244.rtf 0001558370-16-004244.xls
Mar 28, 2016	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001144204-16-090608.pdf 0001144204-16-090608.rtf 0001144204-16-090608.xls
Mar 28, 2016	3/A	An amendment to a 3 filing. Non-EDGAR filing	View HTML 0001179110-16-022254.pdf 0001179110-16-022254.rtf 0001179110-16-022254.xls
Mar 28, 2016	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-022256.pdf 0001179110-16-022256.rtf 0001179110-16-022256.xls
Apr 08, 2016	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-022920.pdf 0001179110-16-022920.rtf 0001179110-16-022920.xls
Apr 13, 2016	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-023027.pdf 0001179110-16-023027.rtf 0001179110-16-023027.xls
Apr 14, 2016	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-023067.pdf 0001179110-16-023067.rtf 0001179110-16-023067.xls

Continue